imported>Bestem |
imported>Bestem |
| Line 1: |
Line 1: |
| ==Quellen== | | ==Quellen== |
| <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
| | Infective endocarditis in adults: diagnosis, antimicrobial therapy and management of complications: a scientific statement for healthcare professionals from the American Heart Association; Circulation (2015); 132(15):1435 |
| mso-fareast-font-family:Calibri;mso-ansi-language:EN-US"><span style="mso-list:Ignore">1. <span style="font:7.0pt "Times New Roman""> </span></span></span><span style="font-size:8.0pt;mso-bidi-font-size:
| |
| 11.0pt;font-family:"Calibri",sans-serif;mso-ansi-language:EN-US">healthcare professionals from the American Heart Association; Circulation (2015); 132(15):1435</span>
| |
|
| |
|
| <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
| | 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC); European Heart Journal (2015); 36(44):3075-3128 |
| mso-fareast-font-family:Calibri;mso-ansi-language:EN-US"><span style="mso-list:Ignore">2. <span style="font:7.0pt "Times New Roman""> </span></span></span><span style="font-size:8.0pt;mso-bidi-font-size:
| |
| 11.0pt;font-family:"Calibri",sans-serif;mso-ansi-language:EN-US">2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC); European Heart Journal (2015); 36(44):3075-3128</span>
| |
|
| |
|
| <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;
| | The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive Summary; The Journal of Thoracic and Cardiovascular Surgery (2017); 153(6):1241 |
| font-family:"Calibri",sans-serif;mso-fareast-font-family:Calibri;mso-ansi-language:
| |
| EN-US"><span style="mso-list:Ignore">3. <span style="font:7.0pt "Times New Roman""> </span></span></span><span style="font-size:8.0pt;mso-bidi-font-size:
| |
| 11.0pt;font-family:"Calibri",sans-serif;mso-ansi-language:EN-US">The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive Summary; The Journal of Thoracic and Cardiovascular Surgery (2017); 153(6):1241</span>
| |
|
| |
|
| <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif;
| | 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017 Dec;14(12):e503-e551 |
| mso-fareast-font-family:Calibri;mso-ansi-language:EN-US"><span style="mso-list:Ignore">4. <span style="font:7.0pt "Times New Roman""> </span></span></span><span style="font-size:8.0pt;mso-bidi-font-size:
| |
| 11.0pt;font-family:"Calibri",sans-serif;mso-ansi-language:EN-US">2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017 Dec;14(12):e503-e551</span>
| |
|
| |
|
| <span style="mso-list:Ignore">5. <span style="font:7.0pt "Times New Roman""> </span></span><span style="font-size:8.0pt;mso-bidi-font-size:
| | Focaccia Siciliano R, Azevedo Randi B, Menosi Gualandro D et al: Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Inf Dis 2018, 67: 3-6. |
| 11.0pt;font-family:"Calibri",sans-serif;mso-ansi-language:EN-US">Focaccia Siciliano R, Azevedo Randi B, Menosi Gualandro D et al: Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Inf Dis 2018, 67: 3-6.</span>
| | |
| | POET - partial oral treatment of left-sided infectious endocarditis; Ivesen K et al. N Engl J Med. 28. August 2018. <nowiki>https://doi.org/10.1056/NEJMoa1808312</nowiki> |
| | |
| | Cahill TJ, Prendergast BD: Infective Endocarditis. Lancet 2016; 387:882-93. |
|
| |
|
| <span style="mso-list:Ignore">6. <span style="font:7.0pt "Times New Roman""> </span></span><span style="color: #222222">POET - partial oral treatment of left-sided infectious endocarditis; Ivesen K et al. </span>N Engl J Med. 28. August 2018. <nowiki>https://doi.org/10.1056/NEJMoa1808312</nowiki>
| |
| <br /> | | <br /> |
Quellen
Infective endocarditis in adults: diagnosis, antimicrobial therapy and management of complications: a scientific statement for healthcare professionals from the American Heart Association; Circulation (2015); 132(15):1435
2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC); European Heart Journal (2015); 36(44):3075-3128
The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive Summary; The Journal of Thoracic and Cardiovascular Surgery (2017); 153(6):1241
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017 Dec;14(12):e503-e551
Focaccia Siciliano R, Azevedo Randi B, Menosi Gualandro D et al: Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Inf Dis 2018, 67: 3-6.
POET - partial oral treatment of left-sided infectious endocarditis; Ivesen K et al. N Engl J Med. 28. August 2018. https://doi.org/10.1056/NEJMoa1808312
Cahill TJ, Prendergast BD: Infective Endocarditis. Lancet 2016; 387:882-93.
